Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • HUT vs MRNA✓SelectedUSD · MRNAHUT vs MRNA performance historyLatest closeAs of+5.97%11/18
Stock and ETF performance explorer

HUT vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+477.7%
MRNA return
+156.2%
Excess return
+321.4%
Maximum drawdown
-65.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D+6.0%-4.8%+10.8%+6.4%
7D-6.3%-20.9%+14.5%-4.4%
30D-16.1%-13.3%-2.8%-15.3%
3M-29.2%+212.6%-241.8%-41.4%
6M-40.6%+309.0%-349.6%-55.6%
YTD+24.5%+567.3%-542.8%-18.7%
1Y+47.9%+689.7%-641.8%-7.1%
All+477.7%+156.2%+321.4%+316.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling